Phase I trial of total androgen blockade, weekly docetaxel, and image-guided intensity-modulated radiotherapy for localized high-risk prostate adenocarcinoma.
Stephen J. Ramey
No relevant relationships to disclose
Ali Reza Golshayan
No relevant relationships to disclose
Thomas E. Keane
No relevant relationships to disclose
Andrew S. Kraft
No relevant relationships to disclose
Uzair Bashir Chaudhary
No relevant relationships to disclose
David T. Marshall
No relevant relationships to disclose